Confronting Pancreatic Cancer

Pancreatic Home Pancreas Cancer News & Archives Links for Pancreas Cancer FAQ Search Pancreatic Trials Pancreatic Research Resources About Pancreatica Make a donation to Pancreatica

Confronting Pancreatic Cancer

Back to Database

How to Use the Pancreatic Cancer Clinical Trials Database

 

NCI Publication: "Understanding Clinical Trials"

 

For educational purposes only; not to be relied upon. Please read Pancreatica Disclaimer

 

General

Selected Nuts and Bolts of the Database

Searching Strategies

 

General

This is a searchable database of clinical trials against cancer of the pancreas. The largest in the world. The database consists both of ongoing clinical trials directly related to pancreas cancer and of those related to general or "solid" tumors (including pancreatic cancer) using drug-agents which are of interest to researchers in the field of pancreatic cancer. There are a number of terms and concepts which are used in this database which are explained in the FAQ or other sections of this web-site. Before proceeding further, please review the Disclaimer. Also, please review the section on clinical trials in the FAQ section of this site, and the NCI publication, "Understanding Clinical Trials."

The clinical trials database is not an exhaustive list of all of the trials which are ongoing for pancreatic cancer. The listing of the clinical trials is in an arbitrary or random order. Clinical trials occurring in other countries may not be approved by the U.S. FDA and may not meet the standards of the FDA. There are advantages and disadvantages to clinical trials, and you need to be fully aware of these before entering a clinical trial.

Pancreatica.org receives no remuneration related to patients joining any of the clinical trials which are listed on this site. Although aspects of the database are updated regularly, major updates are only done on a periodic basis (several times per year). Thus, some trial information may not be current. If you find information which is not current, please contact the Webmaster. Patients are strongly encouraged to work closely with their own physicians and health care providers in making treatment decisions.

Typically, the terms of a clinical trial are spelled out in a large document which is called a protocol. Some of the information in this database has been gathered from such sources. There may be errors in the database, so you should double-check any of this information with the institution or the sponsor of the trial. If you find any errors in our database, please let us know at webmaster@pancreatica.org.

The sequence of a clinical trials database search is as follows. On the Database Search page you select a type of search, including the search criteria. After completing the search, a Mini View of all of the consistent trials is displayed. Then, upon clicking on the Trial Name section of a given trial in the Mini View, the Full View of that clinical trial will be displayed.


Selected Nuts and Bolts of the Database

The Trial ID number is an identifier which is internally generated by us. It is used for reference and as way to get back to a trial which may be of interest to a visitor.

The Phase of the trials are given in numeric numbers (rather than Roman numerals). Occasionally a trial will be a phase I/II trial; this is listed as 1/2 and is listed under phase 2 trials.

There are several nomenclatures for the staging of pancreatic cancer. This whole topic is controversial. The way in which we have presented this in the database is as follows. The five listed disease stages are: Potentially surgically resectable, Locally advanced, Advanced, Not specified and Other. The "Potentially surgically resectable" category roughly corresponds to Stage I; "Locally advanced" includes much of what might be classified as Stage II; and the "Advanced" category includes such classifications--from other nomenclatures--as: non-resectable, refractory, recurrent, metastatic, loco-regional, stage IV, stage III, and possibly even certain extensive stage II tumors.

"Main exclusion criteria" has to do with factors which may disqualify you for the clinical trial.

"Prior therapy allowed" indicates whether the protocol of the clinical trial will allow you to participate in the trial if you have already had certain other previous treatments.

"Treatment interval" refers to the minimum amount of time that the protocol may require you to be off of therapy before beginning the clinical trial.

The "Bibliography" is a section of the database which typically gives medical article citations, as selected by us, that may roughly apply to the clinical trial.


Searching Strategies

Of the approximately ten ways to search the database, depending on individual characteristics some are more practical than others.

If you are on therapy or have had treatment for pancreatic cancer, it may save time to first search by "Prior therapy allowed." Location searches allow U.S. State searches, as well as that of most areas of the world (a Keyword search will look for cities). The Treatment section is based on our category classification. For example, a search for vaccine trials against pancreatic cancer would be initiated by clicking the drop-down menu under Immunotherapy. As hinted at above, a Keyword search can be used in any number of ways. And finally, the Advanced searching function allows for multiple variables to be used in a given query.


Patients are strongly encouraged to work closely with their own physicians and health care providers in making treatment decisions.

 
 


Home | In The News | Links | Donations
FAQ
| Clinical Trials Registry | Research Resources | About Us
   
 
 

 webmaster
   
 

©2000-2005 Pancreatica.org - All Rights Reserved
www.pancreatica.org